Summary
Patients taking weight-loss medicines such as Novo Nordisk A/Ss Ozempic and Wegovy are at risk of developing an eye condition that can cause vision loss, according to Europes drug regulator.
Source: Bloomberg
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
